《病毒纯化与分析》PPT课件.ppt_第1页
《病毒纯化与分析》PPT课件.ppt_第2页
《病毒纯化与分析》PPT课件.ppt_第3页
《病毒纯化与分析》PPT课件.ppt_第4页
《病毒纯化与分析》PPT课件.ppt_第5页
已阅读5页,还剩16页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

Virus purification and analysis using OptiPrep - competitive media,Sucrose Glycerol Caesium chloride,SOLUTION HANDLING,Density solutions prepared by diluting OptiPrep with culture medium or any balanced salt solution (Application Sheet V01) Sterile solution CsCl/sucrose solutions require lengthy preparation times and sterilization CsCl is expensive,CsCl PROBLEMS,Big losses in viral infectivity; low recoveries; high particle:infectivity ratios Solutions have very high osmolality: viruses lose water; high virus density; high CsCl required for gradients Highly toxic to cells: must be dialyzed prior to re-infection of cells Solutions ionic and corrosive: samples must be dialyzed before electrophoresis or HPLC,SUCROSE PROBLEMS (I),Solutions are hyperosmotic: virus density in sucrose usually higher than in iodixanol Solutions are viscous: slow sedimentation of virus particles Highly toxic to cells: must be dialyzed prior to re-infection of cells,OPTIPREP NO PROBLEMS,Solutions are isoosmotic: virus density is low Solutions have low viscosity: rapid sedimentation of virus particles Is non-toxic to cells Has little or no effect on virus infectivity Cells can be re-infected and electrophoresis and HPLC performed without dialysis,Virus banding density,Effect of medium on PM2 infectivity,Sucrose gradients cause loss of virus surface glycoproteins; no loss with iodixanol gradients Infectivity recoveries are 10-100x greater in iodixanol than in sucrose,SUCROSE PROBLEMS (II): for enveloped viruses, particularly retroviruses,350,000g 1 h,rAAV in discontinuous gradient (V04) Zolotukhin S. et al (1999) Gene Therapy, 6, 973-985,rAAV in continuous gradient (V04) Hermans, W.T.J.M.C. et al (1999) Human Gene Therapy, 10, 1885-1891,Gradient Master profiles from 10% and 40% iodixanol at 80 and 20 rpm: effect of time,3 Formats for separation of particles according to their density,rAAV in continuous gradient (V04) Hermans, W.T.J.M.C. et al (1999) Human Gene Therapy, 10, 1885-1891,Comparison of rAAV in CsCl and OptiPrep,Data from Hermans, WTJMC et al (1999) Human Gene Therapy, 10, 1885-1891,Use of self-generated iodixanol gradients in vertical rotors for virus purification and analysis,Virus purification flow-chart without virus pelleting,Purification of Herpes virus in self-generated 25% iodixanol gradient (V05),Purification of retrovirus: self-generated gradient (V09) Moller-Larsen A & Christensen, T. (1998) J. Virol Meth., 73, 151-161,OptiPrepApplication Sheets for:,Adenovirus Ebola virus Foamy virus Herpes simplex virus HIV-1 Human papillomavirus Lassa virus Murine leukemia virus Murine oncornavirus,Norwalk virus Polyoma virus rAAV Rabies virus Rous sarcoma virus Retroviruses Semliki Forest virus SARS Corona virus Vaccinia virus,Publications database on viruses,OptiPrep (since 1994) over 600 Nycodenz (since 1984) approx 70 Using either the Applicati

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论